Similar articles

• Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy.

  Chretien PB, Lipson SD, Makuch RW, Kenady DE, Cohen MH. Chretien PB, et al. Ann N Y Acad Sci. 1979;332:135-47. doi: 10.1111/j.1749-6632.1979.tb47107.x. Ann N Y Acad Sci. 1979. PMID: 316979 No abstract available.
• Immunologic reconstitution of patients with primary immunodeficiency diseases and cancer after treatment with thymosin.

  Goldstein AL, Thurman GB, Rossio JL, Costanzi JJ. Goldstein AL, et al. Transplant Proc. 1977 Mar;9(1):1141-4. Transplant Proc. 1977. PMID: 325742 No abstract available.
• Thymosin for immunodeficiency diseases and cancer.

  Goldstein AL, Rossio JL. Goldstein AL, et al. Compr Ther. 1978 Feb;4(2):49-57. Compr Ther. 1978. PMID: 624213 No abstract available.
• Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.

  Goldstein AL. Goldstein AL. Antibiot Chemother (1971). 1978;24:47-59. doi: 10.1159/000401500. Antibiot Chemother (1971). 1978. PMID: 350140 Review. No abstract available.
• [Results and prospects of using thymosin for the purpose of regulating the immune system in different pathological processes and states].

  Grinevich IuA, Kamenets LIa. Grinevich IuA, et al. Zh Mikrobiol Epidemiol Immunobiol. 1979 Dec;(12):9-15. Zh Mikrobiol Epidemiol Immunobiol. 1979. PMID: 390944 Review. Russian. No abstract available.